Akums Drugs & Pharmaceuticals Ltd.

NSE: AKUMS | BSE: 544222 | ISIN: INE09XN01023 | Industry: Pharmaceuticals
|
501.2000 14.85 (3.05%)
NSE Apr 21, 2025 15:31 PM
Volume: 369.6K
 

logo
Akums Drugs & Pharmaceuticals Ltd.
09 Feb 2025
501.20
3.05%
buy
by ICICI Securities Limited
Target: 710 | Upside : 41.7%
ICICI Securities Limited
Akums Drugs and Pharmaceuticals (Akums) in Q3FY25 saw its CDMO business’ volumes recovering (+0.6% YoY). Growth in CDMO should pick up in the next few quarters given Akums’ healthy order book alongside API prices also settling.
 
Akums Drugs & Pharmaceuticals Ltd. has lost -44.92% in the last 6 Months
More from Akums Drugs & Pharmaceuticals Ltd.
Recommended
Market closes higher, Jio Financial Services' net profit grows by 1.8% YoY to Rs 316.1 crore in Q4
Trendlyne Marketwatch | 21 Apr 2025, 04:26PM
IPOs This Week: Tankup Engineers' Issue Opens
| 21 Apr 2025, 04:01PM
Five Interesting Stocks Today - April 17, 2025
The Baseline | 17 Apr 2025